{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:42Z","timestamp":1791357282889,"version":"4.3.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007914","name":"UT Southwestern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012184","name":"Hersh Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012184","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.bbi.2017.07.005","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T16:46:32Z","timestamp":1499532392000},"page":"103-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection"],"prefix":"10.1016","volume":"66","author":[{"given":"Manish K.","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu","family":"Minhajuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharathi S.","family":"Gadad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy L.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taryn L.","family":"Mayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar H.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2017.07.005_b0005","first-page":"223","article-title":"Chapter 9 - Pharmacological and Neurotoxicological Actions Mediated By Bupropion and Diethylpropion","volume":"Vol. 88","author":"Arias","year":"2009"},{"issue":"8","key":"10.1016\/j.bbi.2017.07.005_b0010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1176\/appi.ajp.2015.14020181","article-title":"Depression subtypes in predicting antidepressant response: a report from the iSPOT-D trial","volume":"172","author":"Arnow","year":"2015","journal-title":"Am. J. Psychiatr."},{"issue":"9","key":"10.1016\/j.bbi.2017.07.005_b0015","first-page":"395","article-title":"Bupropion: a review of its mechanism of antidepressant activity","volume":"56","author":"Ascher","year":"1995","journal-title":"J. Clin. Psychiatr."},{"issue":"7","key":"10.1016\/j.bbi.2017.07.005_b0020","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.biopsych.2012.09.021","article-title":"Inflammatory T Helper 17 Cells Promote Depression-like Behavior in Mice","volume":"73","author":"Beurel","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2017.07.005_b0025","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.intimp.2005.12.007","article-title":"A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice","volume":"6","author":"Brustolim","year":"2006","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.bbi.2017.07.005_b0030","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.psychres.2010.10.029","article-title":"Emerging tendency towards autoimmune process in major depressive patients: a novel insight from Th17 cells","volume":"188","author":"Chen","year":"2011","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.bbi.2017.07.005_b0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.bbi.2017.07.005_b0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nri2295","article-title":"TH17 cells in development: an updated view of their molecular identity and genetic programming","volume":"8","author":"Dong","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.bbi.2017.07.005_b0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.2011.150318","article-title":"The anti-inflammatory effects of sympathectomy in murine antigen-induced arthritis are associated with a reduction of Th1 and Th17 responses","volume":"71","author":"Ebbinghaus","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.bbi.2017.07.005_b0050","doi-asserted-by":"crossref","first-page":"284","DOI":"10.47102\/annals-acadmedsg.V44N8p284","article-title":"Thyroid autoimmune antibodies and major depressive disorder in women","volume":"44","author":"Fam","year":"2015","journal-title":"Ann. Acad. Med. Singapore"},{"issue":"3","key":"10.1016\/j.bbi.2017.07.005_b0055","first-page":"106","article-title":"15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL","volume":"7","author":"Fava","year":"2005","journal-title":"Primary Care Companion to J. Clin. Psychiatr."},{"issue":"2","key":"10.1016\/j.bbi.2017.07.005_b0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1176\/appi.ajp.2015.15060788","article-title":"Clinical experience with high-dosage pramipexole in patients with treatment-resistant depressive episodes in unipolar and bipolar depression","volume":"173","author":"Fawcett","year":"2016","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.bbi.2017.07.005_b0065","doi-asserted-by":"crossref","DOI":"10.1007\/7854_2016_13","article-title":"The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications","author":"Felger","year":"2016","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.bbi.2017.07.005_b0070","article-title":"Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression","author":"Felger","year":"2015","journal-title":"Mol. Psychiatr."},{"issue":"10","key":"10.1016\/j.bbi.2017.07.005_b0075","first-page":"1","article-title":"Practice guideline for the Treatment of Patients With Major Depressive Disorder Third Edition","volume":"167","author":"Gelenberg","year":"2010","journal-title":"Am. J. Psychiatr."},{"issue":"11","key":"10.1016\/j.bbi.2017.07.005_b0080","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2017.07.005_b0085","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1038\/tp.2015.9","article-title":"RNA expression profiling in depressed patients suggests retinoid-related orphan receptor alpha as a biomarker for antidepressant response","volume":"5","author":"Hennings","year":"2015","journal-title":"Transl. Psychiatr."},{"issue":"10","key":"10.1016\/j.bbi.2017.07.005_b0090","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jpsychires.2011.04.009","article-title":"Impact of antipsychotics on cytokine production in-vitro","volume":"45","author":"Himmerich","year":"2011","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.bbi.2017.07.005_b0095","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1096\/fj.09-141978","article-title":"Cellular mechanisms of IL-17-induced blood-brain barrier disruption","volume":"24","author":"Huppert","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bbi.2017.07.005_b0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psyneuen.2017.01.023","article-title":"Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial","volume":"78","author":"Jha","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2017.07.005_b0105","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1038\/emi.2013.58","article-title":"IL-17 cytokines in immunity and inflammation","volume":"2","author":"Jin","year":"2013","journal-title":"Emerg. Microbes. Infect."},{"issue":"1","key":"10.1016\/j.bbi.2017.07.005_b0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00737-016-0672-y","article-title":"Cytokine profile and maternal depression and anxiety symptoms in mid-pregnancy\u2014the FinnBrain Birth Cohort Study","volume":"20","author":"Karlsson","year":"2017","journal-title":"Arch. Women's Mental Health"},{"issue":"1\u20132","key":"10.1016\/j.bbi.2017.07.005_b0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jneuroim.2007.11.006","article-title":"Production and functions of IL-17 in microglia","volume":"194","author":"Kawanokuchi","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.bbi.2017.07.005_b0120","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bbi.2017.07.005_b0125","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4306\/pi.2013.10.3.294","article-title":"Plasma levels of IL-23 and IL-17 before and after antidepressant treatment in patients with major depressive disorder","volume":"10","author":"Kim","year":"2013","journal-title":"Psychiatr. Investig."},{"issue":"6","key":"10.1016\/j.bbi.2017.07.005_b0130","doi-asserted-by":"crossref","first-page":"e64971","DOI":"10.1371\/journal.pone.0064971","article-title":"Inflammatory proteins in plasma are associated with severity of Alzheimer\u2019s disease","volume":"8","author":"Leung","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbi.2017.07.005_b0135","article-title":"Pramipexole, a dopamine D2\/D3 receptor-preferring agonist, prevents experimental autoimmune encephalomyelitis development in mice","author":"Lieberknecht","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.bbi.2017.07.005_b0140","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.4049\/jimmunol.1102527","article-title":"Induction of endothelial nitric oxide synthase expression by IL-17 in human vascular endothelial cells: implications for vascular remodeling in transplant vasculopathy","volume":"188","author":"Liu","year":"2012","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"issue":"2","key":"10.1016\/j.bbi.2017.07.005_b0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1756-185X.2011.01673.x","article-title":"The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis","volume":"15","author":"Liu","year":"2012","journal-title":"Int. J. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.bbi.2017.07.005_b0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/157015912800604542","article-title":"Immunomodulation mechanism of antidepressants: interactions between serotonin\/norepinephrine balance and Th1\/Th2 balance","volume":"10","author":"Martino","year":"2012","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2017.07.005_b0155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.21500\/20112084.854","article-title":"How to factor-analyze your data right: do\u2019s, don\u2019ts, and how-to\u2019s","volume":"3","author":"Matsunaga","year":"2015","journal-title":"Int. J. Psychol. Res."},{"key":"10.1016\/j.bbi.2017.07.005_b0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2016.01.020","article-title":"The role of dopamine in modulation of Th-17 immune response in multiple sclerosis","volume":"292","author":"Melnikov","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.bbi.2017.07.005_b0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bbi.2017.07.005_b0170","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/npp.2016.167","article-title":"Therapeutic implications of brain-immune interactions: treatment in translation","volume":"42","author":"Miller","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.bbi.2017.07.005_b0175","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bbi.2017.07.005_b0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatr."},{"issue":"5","key":"10.1016\/j.bbi.2017.07.005_b0185","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2017.07.005_b0190","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.biopsych.2005.08.022","article-title":"An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report","volume":"59","author":"Rush","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.bbi.2017.07.005_b0195","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa052963","article-title":"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression","volume":"354","author":"Rush","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bbi.2017.07.005_b0200","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR\u2217D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatr."},{"issue":"7","key":"10.1016\/j.bbi.2017.07.005_b0205","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1176\/appi.ajp.2011.10111645","article-title":"Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study","volume":"168","author":"Rush","year":"2011","journal-title":"Am. J. Psychiatr."},{"issue":"8","key":"10.1016\/j.bbi.2017.07.005_b0210","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1176\/appi.ajp.2015.14050680","article-title":"ABCB1 genetic effects on antidepressant outcomes: a report from the iSPOT-D trial","volume":"172","author":"Schatzberg","year":"2015","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.bbi.2017.07.005_b0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2013.06.006","article-title":"Citalopram suppresses thymocyte cytokine production","volume":"262","author":"Shenoy","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.bbi.2017.07.005_b0220","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: a meta-analysis","volume":"25","author":"Strawbridge","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2017.07.005_b0225","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neubiorev.2016.02.017","article-title":"Mapping inflammation onto mood: inflammatory mediators of anhedonia","volume":"64","author":"Swardfager","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2017.07.005_b0230","first-page":"6","article-title":"Biomarkers and the future of treatment for depression","volume":"2012","author":"Toups","year":"2012","journal-title":"Cerebrum"},{"issue":"1","key":"10.1016\/j.bbi.2017.07.005_b0235","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0033291703001107","volume":"34","author":"Trivedi","year":"2004","journal-title":"Psychol. Med."},{"issue":"12","key":"10.1016\/j.bbi.2017.07.005_b0240","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIs for depression","volume":"354","author":"Trivedi","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbi.2017.07.005_b0245","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR\u2217D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatr."},{"issue":"12","key":"10.1016\/j.bbi.2017.07.005_b0250","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am. J. Psychiatr."},{"issue":"12","key":"10.1016\/j.bbi.2017.07.005_b0255","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1038\/npp.2014.141","article-title":"Lipopolysaccharide reduces incentive motivation while boosting preference for high reward in mice","volume":"39","author":"Vichaya","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.bbi.2017.07.005_b0260","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00401-015-1402-7","article-title":"The role of IL-17 in CNS diseases","volume":"129","author":"Waisman","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"22","key":"10.1016\/j.bbi.2017.07.005_b0265","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1073\/pnas.1104836108","article-title":"Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans","volume":"108","author":"Warner-Schmidt","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.bbi.2017.07.005_b0270","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00131746-200603000-00002","article-title":"Self-rated global measure of the frequency, intensity, and burden of side effects","volume":"12","author":"Wisniewski","year":"2006","journal-title":"J. Psychiatr. Practice"},{"issue":"6","key":"10.1016\/j.bbi.2017.07.005_b0275","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/1074-7613(95)90070-5","article-title":"Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor","volume":"3","author":"Yao","year":"1995","journal-title":"Immunity"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915911730212X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915911730212X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:50:40Z","timestamp":1760169040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088915911730212X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":55,"alternative-id":["S088915911730212X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2017.07.005","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2017.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}